EP3967307A1 - USE OF PIM KINASE INHIBITORS TO AUGMENT THE EFFICACY OF ANTI-CD20 ANTIBODY-BASED THERAPIES IN HEMATOLOGIC MALIGNANCIES AND NON-MALIGNANT CONDITIONS